Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A-Mark Precious Metals | AMRK | Mar 28, 2025 | 26.45 | -6.90 |
a.k.a Brands | AKA | Mar 28, 2025 | 14.29 | -0.97 |
A.O Smith | AOS | Mar 28, 2025 | 65.61 | -1.93 |
A10 Networks | ATEN | Mar 28, 2025 | 16.74 | -3.07 |
A2Z Cust2Mate Solutions | AZ | Mar 28, 2025 | 7.31 | -1.48 |
AA Mission Acquisition | AAM | Mar 28, 2025 | 10.28 | +0.10 |
AAA - A Rated Corporate Bond Ishares | QLTA | Mar 28, 2025 | 47.44 | +0.47 |
Aadi Bioscience | AADI | Mar 28, 2025 | 2.05 | 0.00 |
AAON | AAON | Mar 28, 2025 | 78.08 | -2.69 |
AAR | AIR | Mar 28, 2025 | 57.14 | -16.40 |
Aardvark Therapeutics | AARD | Mar 28, 2025 | 7.74 | 0.00 |
Abacus Global Management | ABL | Mar 28, 2025 | 7.62 | +6.57 |
Abbott Laboratories | ABT | Mar 28, 2025 | 130.82 | -0.40 |
AbbVie | ABBV | Mar 28, 2025 | 205.29 | +1.27 |
AbCellera Biologics | ABCL | Mar 28, 2025 | 2.31 | -2.12 |
Abeona Therapeutics | ABEO | Mar 28, 2025 | 4.97 | -1.39 |
Abercrombie & Fitch | ANF | Mar 28, 2025 | 76.57 | -1.24 |
Aberdeen Asia-Pacificome Fund | FAX | Mar 28, 2025 | 15.67 | +0.19 |
Aberdeen Australia Equity Fund | IAF | Mar 28, 2025 | 4.06 | -0.25 |
Aberdeen Emerging Markets Fund | AEF | Mar 28, 2025 | 5.00 | -1.96 |
Aberdeen Global Fund | FCO | Mar 28, 2025 | 6.03 | +0.33 |
Aberdeen Global Infrastructure | ASGI | Mar 28, 2025 | 18.49 | +0.98 |
Aberdeen Income Credit Strategies Fund | ACP | Mar 28, 2025 | 5.91 | -0.17 |
Aberdeen Income Credit Strategies Pref | ACP-A | Mar 28, 2025 | 21.43 | -0.65 |
Aberdeen Japan Equity Fund | JEQ | Mar 28, 2025 | 6.59 | -1.64 |
Abits Group | ABTS | Mar 28, 2025 | 3.28 | +3.71 |
Abivax SA - American Depositary Shares | ABVX | Mar 28, 2025 | 6.43 | -5.72 |
Able View Global | ABLV | Mar 28, 2025 | 0.95 | +5.34 |
ABM Industries | ABM | Mar 28, 2025 | 47.32 | -1.79 |
Above Food Ingredients | ABVE | Mar 28, 2025 | 0.58 | -15.31 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.